GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,679,000 | +1377.2% | 572,311 | +801.4% | 0.01% | +600.0% |
| Q4 2020 | $926,000 | +48.4% | 63,489 | +44.7% | 0.00% | – |
| Q3 2020 | $624,000 | -94.4% | 43,877 | -94.2% | 0.00% | -100.0% |
| Q2 2020 | $11,215,000 | +2048.5% | 762,373 | +501.8% | 0.01% | – |
| Q1 2020 | $522,000 | -60.6% | 126,683 | -54.1% | 0.00% | -100.0% |
| Q4 2019 | $1,326,000 | -15.5% | 276,161 | +6.5% | 0.00% | 0.0% |
| Q3 2019 | $1,570,000 | -24.6% | 259,282 | -19.3% | 0.00% | 0.0% |
| Q2 2019 | $2,083,000 | +4.1% | 321,211 | +13.7% | 0.00% | 0.0% |
| Q1 2019 | $2,001,000 | +110.9% | 282,486 | +44.6% | 0.00% | 0.0% |
| Q4 2018 | $949,000 | -76.1% | 195,417 | -63.9% | 0.00% | 0.0% |
| Q3 2018 | $3,977,000 | +230.9% | 541,343 | +186.9% | 0.00% | – |
| Q2 2018 | $1,202,000 | +205.9% | 188,657 | +160.2% | 0.00% | – |
| Q1 2018 | $393,000 | -19.0% | 72,509 | -37.8% | 0.00% | – |
| Q4 2017 | $485,000 | -64.7% | 116,512 | -18.3% | 0.00% | -100.0% |
| Q3 2017 | $1,372,000 | -40.7% | 142,541 | -27.1% | 0.00% | -50.0% |
| Q2 2017 | $2,312,000 | +1.3% | 195,624 | +9.8% | 0.00% | 0.0% |
| Q1 2017 | $2,282,000 | +113.1% | 178,223 | +103.2% | 0.00% | +100.0% |
| Q4 2016 | $1,071,000 | -43.3% | 87,704 | -45.2% | 0.00% | 0.0% |
| Q3 2016 | $1,888,000 | -27.7% | 160,072 | -46.8% | 0.00% | -50.0% |
| Q2 2016 | $2,613,000 | +94.0% | 300,649 | +17.5% | 0.00% | +100.0% |
| Q1 2016 | $1,347,000 | -32.5% | 255,941 | -0.5% | 0.00% | 0.0% |
| Q4 2015 | $1,995,000 | -2.2% | 257,195 | -0.8% | 0.00% | -50.0% |
| Q3 2015 | $2,039,000 | -12.6% | 259,203 | +0.6% | 0.00% | +100.0% |
| Q2 2015 | $2,332,000 | -28.0% | 257,531 | +3.2% | 0.00% | -50.0% |
| Q1 2015 | $3,238,000 | +309.4% | 249,550 | +329.1% | 0.00% | – |
| Q4 2014 | $791,000 | +12.5% | 58,150 | -25.9% | 0.00% | – |
| Q3 2014 | $703,000 | -42.4% | 78,465 | -13.1% | 0.00% | -100.0% |
| Q2 2014 | $1,220,000 | +9.7% | 90,256 | -19.4% | 0.00% | 0.0% |
| Q1 2014 | $1,112,000 | -24.7% | 111,913 | +0.7% | 0.00% | 0.0% |
| Q4 2013 | $1,476,000 | -52.3% | 111,165 | -56.4% | 0.00% | -50.0% |
| Q3 2013 | $3,094,000 | – | 255,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |